I agree that this site is using cookies. You can find further informations here.
X
Larouche, Valerie
161  results:
Search for persons X
?
1

LGG-51. SYSTEMIC IMMUNE TOXICITY OF BRAF AND MEK-INHIBITORS..:

McKeown, Tara ; Renzi, Samuele ; Larouche, Valerie...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
2

HGG-39. CLINICAL CHARACTERISTICS AND SURVIVAL OUTCOMES OF D..:

Crowell, Cameron ; Bennett, Julie ; Bandopadhayay, Pratiti...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
3

Recurrent primary intracranial sarcoma, DICER1-mutant in a ..:

Lachance, Alexandre ; Dimentberg, Evan ; Huang, Sidong...
Child's Nervous System.  40 (2024)  6 - p. 1965-1969 , 2024
Link: https://doi.org/10.1007/..
 
?
4

LGG-40. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRA..:

Kline, Cassie ; Waanders, Angela J ; Ziegler, David S...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
5

Advances in pediatric gliomas: from molecular characterizat..:

Sathyakumar, Sayanthen ; Martinez, Matthew ; Perreault, Sébastien...
European Journal of Pediatrics.  183 (2024)  6 - p. 2549-2562 , 2024
Link: https://doi.org/10.1007/..
 
?
6

Epidemiology of Pediatric Tumors in Quebec: A 17-Year Repor..:

Bellavance, Caroline ; Lalonde, Benoit ; Simonyan, David...
Current Oncology.  31 (2024)  5 - p. 2689-2699 , 2024
Link: https://doi.org/10.3390/..
 
?
7

LGG-60. DISTRIBUTION AND CLINICAL SIGNIFICANCE OF FGFR ALTE..:

Nobre, Liana ; Farouk, Sameer ; Larsen, Alexandra...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
8

QOL-44. EARLY SEVERE HEARING LOSS IN CANADIAN CHILDREN WITH..:

Coltin, Hallie ; Trudeau-Ferrin, Ofélie ; Perreault, Sébastien...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
9

Impact of trametinib on the neuropsychological profile of N..:

Lalancette, Eve ; Cantin, Édith ; Routhier, Marie-Ève...
Journal of Neuro-Oncology.  167 (2024)  3 - p. 447-454 , 2024
Link: https://doi.org/10.1007/..
 
?
10

Author Correction: The type II RAF inhibitor tovorafenib in..:

Kilburn, Lindsay B. ; Khuong-Quang, Dong-Anh ; Hansford, Jordan R....
Nature Medicine.  30 (2024)  5 - p. 1500-1500 , 2024
Link: https://doi.org/10.1038/..
 
?
11

Germline Platelet-derived growth factor receptor beta p.R98..:

Han, HyeRim ; Renzi, Samuele ; Larouche, Valerie...
Neuro-Oncology Advances.  5 (2023)  1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
12

TMIC-04. IMMUNE PROFILING OF PEDIATRIC ONCOHISTONE GLIOMAS ..:

Andrade, Augusto Faria ; Topouza, Danai ; McNicholas, Michael...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v278-v278 , 2023
Link: https://doi.org/10.1093/..
 
?
13

The type II RAF inhibitor tovorafenib in relapsed/refractor..:

Kilburn, Lindsay B. ; Khuong-Quang, Dong-Anh ; Hansford, Jordan R....
Nature Medicine.  30 (2023)  1 - p. 207-217 , 2023
Link: https://doi.org/10.1038/..
 
?
14

Combined Immunotherapy Improves Outcome for Replication-Rep..:

Das, Anirban ; Fernandez, Nicholas R. ; Levine, Adrian...
Cancer Discovery.  14 (2023)  2 - p. 258-273 , 2023
Link: https://doi.org/10.1158/..
 
?
15

CTNI-37. CLINICAL ACTIVITY OF RAF INHIBITOR TOVORAFENIB ACC..:

Khuong-Quang, Dong-Anh ; Nysom, Karsten ; Landi, Daniel...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v82-v83 , 2023
Link: https://doi.org/10.1093/..
 
1-15